|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Marketable securities | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Note receivable, net | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Operating lease right-of-use asset | ||||||||||||||||||||
| Intangibles, net | ||||||||||||||||||||
| Investments | ||||||||||||||||||||
| Equity method investment, at fair value | ||||||||||||||||||||
| Digital assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other long term assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' DEFICIT | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued payroll | ||||||||||||||||||||
| Accrued rebates and fees | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Current portion of deferred consideration | ||||||||||||||||||||
| Debt, current | ||||||||||||||||||||
| Promissory notes | ||||||||||||||||||||
| Purchased revenue liability, current | ||||||||||||||||||||
| Current portion of operating lease liabilities | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term portion of deferred consideration | ||||||||||||||||||||
| Debt, net of issuance costs | ||||||||||||||||||||
| Purchased revenue liability, net of current portion | ||||||||||||||||||||
| Derivative liabilities | ||||||||||||||||||||
| Operating lease liabilities, net of current portion | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' deficit: | ||||||||||||||||||||
| Preferred Stock, Value | ||||||||||||||||||||
| Series A Preferred Stock | ||||||||||||||||||||
| Series 1 Preferred Stock | ||||||||||||||||||||
| Total preferred Stock, Value | ||||||||||||||||||||
| Common stock, $0.0001 par value, 740,000,000 shares authorized; 8,493,000 shares issued and 7,034,737 shares outstanding as of June 30, 2026; 8,491,267 shares issued and 7,033,004 shares outstanding as of December 31, 2025 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Treasury stock, at cost; 1,458,263 shares as of June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Total Scilex Holding Company stockholders' deficit | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Total stockholders' deficit | ||||||||||||||||||||
| Total liabilities and stockholders' deficit | ||||||||||||||||||||
Loading...